» Articles » PMID: 28934496

Activities of Gyrase and Topoisomerase IV on Positively Supercoiled DNA

Overview
Specialty Biochemistry
Date 2017 Sep 22
PMID 28934496
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Although bacterial gyrase and topoisomerase IV have critical interactions with positively supercoiled DNA, little is known about the actions of these enzymes on overwound substrates. Therefore, the abilities of Bacillus anthracis and Escherichia coli gyrase and topoisomerase IV to relax and cleave positively supercoiled DNA were analyzed. Gyrase removed positive supercoils ∼10-fold more rapidly and more processively than it introduced negative supercoils into relaxed DNA. In time-resolved single-molecule measurements, gyrase relaxed overwound DNA with burst rates of ∼100 supercoils per second (average burst size was 6.2 supercoils). Efficient positive supercoil removal required the GyrA-box, which is necessary for DNA wrapping. Topoisomerase IV also was able to distinguish DNA geometry during strand passage and relaxed positively supercoiled substrates ∼3-fold faster than negatively supercoiled molecules. Gyrase maintained lower levels of cleavage complexes with positively supercoiled (compared with negatively supercoiled) DNA, whereas topoisomerase IV generated similar levels with both substrates. Results indicate that gyrase is better suited than topoisomerase IV to safely remove positive supercoils that accumulate ahead of replication forks. They also suggest that the wrapping mechanism of gyrase may have evolved to promote rapid removal of positive supercoils, rather than induction of negative supercoils.

Citing Articles

Antistaphylococcal Triazole-Based Molecular Hybrids: Design, Synthesis and Activity.

Shabelnyk K, Fominichenko A, Antypenko O, Gaponov O, Koptieva S, Shyshkina S Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861146 PMC: 11769325. DOI: 10.3390/ph18010083.


How Do Gepotidacin and Zoliflodacin Stabilize DNA-Cleavage Complexes with Bacterial Type IIA Topoisomerases? 2. A Single Moving Metal Mechanism.

Nicholls R, Morgan H, Warren A, Ward S, Long F, Murshudov G Int J Mol Sci. 2025; 26(1.

PMID: 39795899 PMC: 11720246. DOI: 10.3390/ijms26010033.


Genetic and in-silico approaches for investigating the mechanisms of ciprofloxacin resistance in : Mutations, extrusion, and antimicrobial resistance.

Khan N, Gillani S, Bhat M, Ullah I, Yaseen M Heliyon. 2024; 10(19):e38333.

PMID: 39397980 PMC: 11470425. DOI: 10.1016/j.heliyon.2024.e38333.


Mechanism of antibacterial resistance, strategies and next-generation antimicrobials to contain antimicrobial resistance: a review.

Belay W, Getachew M, Tegegne B, Teffera Z, Dagne A, Zeleke T Front Pharmacol. 2024; 15:1444781.

PMID: 39221153 PMC: 11362070. DOI: 10.3389/fphar.2024.1444781.


Highly sensitive mapping of in vitro type II topoisomerase DNA cleavage sites with SHAN-seq.

Morgan I, McKie S, Kim R, Seol Y, Xu J, Harami G Nucleic Acids Res. 2024; 52(16):9777-9787.

PMID: 39106172 PMC: 11381365. DOI: 10.1093/nar/gkae638.


References
1.
McCarthy D, Minner C, Bernstein H, Bernstein C . DNA elongation rates and growing point distributions of wild-type phage T4 and a DNA-delay amber mutant. J Mol Biol. 1976; 106(4):963-81. DOI: 10.1016/0022-2836(76)90346-6. View

2.
McClendon A, Osheroff N . The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs. Biochemistry. 2006; 45(9):3040-50. PMC: 2517258. DOI: 10.1021/bi051987q. View

3.
Nollmann M, Stone M, Bryant Z, Gore J, Crisona N, Hong S . Multiple modes of Escherichia coli DNA gyrase activity revealed by force and torque. Nat Struct Mol Biol. 2007; 14(4):264-71. DOI: 10.1038/nsmb1213. View

4.
Fournier B, Zhao X, Lu T, Drlica K, Hooper D . Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis. Antimicrob Agents Chemother. 2000; 44(8):2160-5. PMC: 90029. DOI: 10.1128/AAC.44.8.2160-2165.2000. View

5.
Aldred K, Blower T, Kerns R, Berger J, Osheroff N . Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase. Proc Natl Acad Sci U S A. 2016; 113(7):E839-46. PMC: 4763725. DOI: 10.1073/pnas.1525055113. View